Gainers
CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
AiHuiShou International (RERE)
Century Therapeutics (IPSC)
ATAI Life Sciences (ATAI)
Jaws Juggernaut Acquisition (JUGGU)
Tremor International (TRMR)
Ambrx Biopharma (AMAM)
Cyteir Therapeutics (CYT)
Codex DNA